The Library
Acetazolamide for the prophylaxis of acute mountain sickness
Tools
Tools
Tools
Imray, C. (Chris) (2012) Acetazolamide for the prophylaxis of acute mountain sickness. BMJ, Vol.345 . Article number e7077. doi:10.1136/bmj.e7077 ISSN 0959-535X.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1136/bmj.e7077
Abstract
In 2000, a systematic review concluded that when ascending rapidly to above 4000 m, prophylactic dexamethasone 8-16 mg daily or acetazolamide 750 mg daily both reduced acute mountain sickness.1 However, acetazolamide 500 mg daily was not found be effective. At the time, many doctors who specialise in high altitude sickness thought that this did not reflect their clinical experience, and there were concerns about incomplete inclusion criteria, inadequate control of ascent rates, and unduly strict endpoints.2 3
In a linked systematic review and meta-analysis (doi:10.1136/bmj.e6779), Low and colleagues look at the important question of the efficacy of acetazolamide at lower doses to prevent acute mountain sickness above 3000 m.4 They found that acetazolamide 250 mg and 500 mg daily were both effective in reducing the severity of acute mountain sickness. The different altitudes studied (3000 v 4000 m) could have led to differences in the incidence and severity of acute mountain sickness and may partly account for the studies’ different conclusions.1 4
More people are travelling to high altitude for work (soldiers, miners, construction workers, and astronomers) or recreation (skiing, trekking, mountain biking, and mountaineering). On ascent to altitude, several adaptive physiological processes occur (including hyperventilation, erythropoiesis, and increased cardiac output), all of which tend to increase convective oxygen transport to the tissues, a process termed “acclimatisation.”5
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
| Journal or Publication Title: | BMJ | ||||
| Publisher: | BMJ Publishing Group Ltd. | ||||
| ISSN: | 0959-535X | ||||
| Official Date: | 2012 | ||||
| Dates: |
|
||||
| Volume: | Vol.345 | ||||
| Page Range: | Article number e7077 | ||||
| DOI: | 10.1136/bmj.e7077 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
